Skip to main content

Table 2 Antibiotic susceptibility profile of staphylococci isolates recovered from general public settings

From: The prevalence, antibiotic resistance and mecA characterization of coagulase negative staphylococci recovered from non-healthcare settings in London, UK

Isolates

No of isolates

Resistance to a panel of 11 antibiotics (%)

 

OX

PG

MUP

CEF

GM

FC

S

A

E

T

C

S. epidermidis

176

8

72

16

9

7

64

22

26

43

16

2

S. hominis

152

2

68

9

5

7

66

24

17

38

21

3

S. capitis

73

4

58

15

4

1

60

47

23

14

10

5

S. haemolyticus

40

10

50

13

23

15

68

73

45

0

25

10

S. warneri

63

3

54

17

10

22

59

51

40

27

16

2

S. pasteuri

31

6

69

13

6

9

69

25

31

44

17

3

S. saprophyticus

20

15

90

25

5

10

100

10

25

35

15

10

S. aureus

12

0

83

17

0

58

83

33

50

25

0

8

S. simiae

10

0

10

0

0

0

40

0

0

0

0

0

S. cohnii

9

24

67

11

33

0

78

78

22

56

11

0

S. sciuri

5

60

60

80

0

20

80

80

40

0

0

0

S. pettenkoferi

3

0

33

0

0

0

67

67

33

0

0

0

S. lugdunensis

2

0

50

0

0

0

50

0

0

0

0

0

S. equorum

2

0

50

50

0

0

50

50

50

0

50

0

S. caprae

2

0

100

0

100

100

100

50

50

0

0

0

S. xylosus

2

0

100

50

50

50

100

100

0

0

50

0

S. auricularis

2

0

50

0

50

0

50

0

50

0

0

0

S. arlettae

1

0

100

0

0

0

100

100

100

100

0

0

S. simulans

1

0

100

0

0

0

100

0

0

0

0

0

  1. OX oxacillin (1 μg), PG penicillin G (1 unit), MUP mupirocin (20 μg), CEF cefepime (30 μg), GM gentamicin (10 μg), FC fusidic acid (10 μg), S streptomycin (10 μg), A amoxicillin (10 μg), E erythromycin (5 μg), T tetracycline (10 μg), C chloramphenicol (30 μg)